GDTC

Companies
NASDAQ
Cytomed Therapeutics Ltd.
Health Care
Price Chart
Overview

About GDTC

incorporated in 2018, cytomed therapeutics is a spin-off from singapore’s agency for science, technology and research ( a*star) and focuses on translating its patented technologies into gamma delta (γδ) t cell- and natural killer (nk) cell-based “off-the-shelf” immunotherapeutics for a wide range of cancers. we also engage in generating induced pluripotent stem cells (ipscs) and translating them into “off-the-shelf” cellular therapeutics using our proprietary technologies for our customers.

Market Cap
$22.5M
Volume
40.5K
Avg. Volume
31.3K
P/E Ratio
-15.866667
Dividend Yield
0.00%
Employees
17.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.15
Low Correlation
Volatility
High (0.94)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for GDTC.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, GDTC shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$22.5M
Volume40.5K
P/E Ratio-15.87
Dividend Yield0.00%
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how GDTC fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025